ABOUT THERAPEUTIC PSYCHEDELICS

Monoamine oxidase inhibitors (MAOI) are already recognised to prolong and improve the effects of dimethyltryptamine (copyright) and one study assumed that the effect on psilocybin would be very similar as it can be a structural analogue of copyright.[one hundred forty five] Nevertheless, only a little part of psilocin appears for being metabolized